With 9.6% CAGR, Pharmaceutical Continuous Manufacturing Market Size Worth USD 3.24 Billion in 2028 | Zion Market Research | Global Industry Trends, Share, Growth, Value, Analysis & Forecast Report
NEW YORK, June 20, 2022 /PRNewswire/ -- As per Zion Market Research study, The global pharmaceutical continuous manufacturing market was valued at nearly USD 1.53 billion in 2021 and is expected to rise to just over USD 3.24 billion by 2028, with a CAGR of around 9.6% over the forecast period. Continuous manufacturing is a cutting-edge manufacturing method with the capability to enhance the consistency and quality of drugs at a lower cost. This manufacturing line is run at a constant pace, with end-to-end incorporation of manufacturing processes.
Key Industry Insights & Finding of the Pharmaceutical Continuous Manufacturing Market Reports:
- As per the analysis shared by our research analyst, the Pharmaceutical Continuous Manufacturing Market is expected to grow annually at a CAGR of around 9.6 % (2022-2028).
- Through the primary research, it was established that the Pharmaceutical Continuous Manufacturing Market was valued approximately USD 1.53 Billion in 2021 and is projected to reach to roughly USD 3.24 Billion by 2028.
- Key factors such as the existence of several contract manufacturing organizations, as well as strong demand for innovative technologies from pharmaceutical corporations, have fueled the industry in the Europe region.
- The United Kingdom and Germany are driving Europe's growth. In 2021, the region holds over 35 percent of the share also in terms of growth, the market in the region is predicted to outperform others, with a CAGR of 9.6% during the forecast period.
- The Asia Pacific region accounted for around 34 percent of the worldwide pharmaceutical continuous production market in 2021. India and China, which are home to several contract manufacturers, have fueled the market growth in Asia Pacific.
Zion Market Research published the latest report titled as "Pharmaceutical Continuous Manufacturing Market By Product (Integrated Continuous Systems, Semicontinuous Systems, And Control & Software), By Application (Final Drug Product Manufacturing And API Manufacturing), By End User (Pharmaceutical Companies, Contract Manufacturing Organizations, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028." into their research database.
Pharmaceutical Continuous Manufacturing Market : Overview
The ophthalmic ultrasound imaging system is a form of non-invasive viewing technology that is more convenient. Ophthalmic ultrasound imaging devices allow for the imaging of anatomy and disease in the eye's frontal and posterior segments. A transducer probe is put in a medium in ophthalmic ultrasound imaging systems, which creates waves of a certain frequency that impact internal structures in the eye. The waves collected by the transducer, as well as the voltages that arise, are intensified and analyzed to create pictures. Different sorts of modalities are employed according to the ocular disease or disorder.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/ophthalmic-ultrasound-imaging-systems-market
Our Free Sample Report Includes:
- 2022 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 180 + Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Industry Dynamics:
Pharmaceutical Continuous Manufacturing Market : Growth Drivers
- Advancements in technology and improved process quality may benefit the market growth.
Continuous manufacturing refers to the production of a pharmaceutical product in a single continuous process. The entire procedure takes place in one location, from beginning to end, with no wait times. This helps to lower the manufacturing costs, mostly during the long process run. Further, the technological advances aid to minimize the manufacturing time from weeks to days. The advancement in the process also ensures low human errors that aid in quality improvement. Furthermore, continuous manufacturing is a more agile approach that facilitates production scalability. Scaling up, for example, just entails continuing to run the continuous production process for a longer period. In other words, continuous production makes matching supply to demand much easier than batch manufacturing. Continuous manufacturing also enables tracing and tracking more versatile; for example, instead of a batch being specified by the equipment used in its production, a drug's batch amount might be determined by factors such as time or quantity made. This allows for lower batch sizes, resulting in less waste when flaws are discovered in a batch.
Pharmaceutical Continuous Manufacturing Market : Restraints
- High process costs associated with continuous pharmaceutical manufacturing may hinder the market growth.
Continuous pharmaceutical manufacturing promises increases productivity at a given time, however, to maintain the continuous process high cost is needed to be invested. Continuous pharmaceutical production is a complex process that needs to maintain many parameters at certain points thus most of the continuous process runs on automation which adds more cost to the overall process. Additionally, as the nature of the process is continuous there is low scope remaining for changing products. Moreover, since a single defect might halt the entire manufacturing process, high receptivity to malfunctions is required. All these factors may hinder the global pharmaceutical continuous manufacturing market growth over the forecast period.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/pharmaceutical-continuous-manufacturing-market
Global Pharmaceutical Continuous Manufacturing Market : Opportunities
- Increasing investments in process automation in pharmaceutical sectors are expected to offer better growth opportunities to the market.
As the demand for new drugs is rising, manufacturers are shifting their mode of process to increase productivity. Continuous production has several advantages, including increased efficiency (productivity, economy), which is enabled by the interconnection of unit operations such as refining, chemical reactions, and crystallization. Improved product quality and safety, which is enabled by continuous automated monitoring of processes. This aid to reduce environmental impact by reducing waste through a high rate of reaction efficiency and space savings due to the compact size of the equipment sets. All these factors support the adoption of automated production systems in the pharma sector. Besides, many major pharmaceutical manufacturers are expanding their API business in emerging countries which will further support the market expansion during the forecast period.
Global Pharmaceutical Continuous Manufacturing Market : Challenges
- Low adoption of continuous automation process in small and mid-level pharmaceutical companies pose a major challenge for market growth.
The major hindrance to implementing a continuous automation system in a production unit is its cost and complex mechanism. Due to its multiple sensors and operating compartments, a skilled workforce is also required which makes it more tedious to operate. However, such advanced production unit having huge price tag is difficult to set for small-scale manufacturers, which hinders market growth to some extent. Moreover, the number of small-scale drug manufacturers is increasing around the world, in that context the limitations to adopting continuous manufacturing systems by these emerging small-scale manufacturers may limit the market expansion.
Global Pharmaceutical Continuous Manufacturing Market : Segmentation
- The global pharmaceutical continuous manufacturing market is categorized based on product, application, end-user, and region.
By product, the market is bifurcated into semicontinuous systems, integrated continuous systems, and control & software. The application segment of the market includes API manufacturing and final drug product manufacturing. The end-user segment of the market is segregated as contract manufacturing organizations, pharmaceutical companies, and others.
Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/pharmaceutical-continuous-manufacturing-market
List of Key Players of Pharmaceutical Continuous Manufacturing Market :
- Coperion GmbH
- Bosch Packaging Technology
- Gebrüder Lödige Maschinenbau GmbH
- Hosokawa Micron Corporation
- GEA Group AG
- Glatt GmbH
- Korsch AG
- L.B. Bohle Maschinen + Verfahren GmbH
- Thermo Fisher Scientific Inc.
- Munson Machinery Company Inc.
Key questions answered in this report:
- What are the growth rate forecast and market size for Pharmaceutical Continuous Manufacturing Market ?
- What are the key driving factors propelling the Pharmaceutical Continuous Manufacturing Market forward?
- What are the most important companies in the Pharmaceutical Continuous Manufacturing Market Industry?
- What segments does the Pharmaceutical Continuous Manufacturing Market cover?
- How can I receive a free copy of the Pharmaceutical Continuous Manufacturing Market sample report and company profiles?
Report Scope:
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/pharmaceutical-continuous-manufacturing-market
Recent Developments
- September 2021, Thermo Fisher will invest USD 82.5 million to increase production capacity at its biologic drug substance manufacturing facility in St. Louis. The investment will increase the company's entire manufacturing capacity two-fold, serving both short- and long-term COVID-19 requirements.
- September 2021, The Johnson & Johnson manufacturing facility in Ringaskiddy, Ireland, endures to expand. The firm has plans to increase the manufacturing capacity with the completion of a USD 354 million. This investment brings the total amount invested in the biologics production plant to USD 176 million.
Regional Dominance:
- Europe to lead the global market over the forecast period.
The global pharmaceutical continuous manufacturing market is largely dominated by Europe. Key factors such as the existence of several contract manufacturing organizations, as well as strong demand for innovative technologies from pharmaceutical corporations, have fueled the industry in the region. The United Kingdom and Germany are driving Europe's growth. In 2021, the region holds over 35 percent of the share also in terms of growth, the market in the region is predicted to outperform others, with a CAGR of 9.6% during the forecast period. This is due to the early availability of modern technologies and the increased number of technology suppliers around the area. In terms of market share, Asia Pacific lags behind Europe. The region accounted for around 34 percent of the worldwide pharmaceutical continuous production market in 2021. India and China, which are home to several contract manufacturers, have fueled the market growth in Asia Pacific.
Global Pharmaceutical Continuous Manufacturing Market is segmented as follows:
Pharmaceutical Continuous Manufacturing Market : By Product Outlook (2022-2028)
- Integrated Continuous Systems
- Semicontinuous Systems
- Control & Software
Pharmaceutical Continuous Manufacturing Market : By Application Outlook (2022-2028)
- Final Drug Product Manufacturing
- API Manufacturing
Pharmaceutical Continuous Manufacturing Market : By End User Outlook (2022-2028)
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- Others
Pharmaceutical Continuous Manufacturing Market : By Region Outlook (2022-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Press Release For Pharmaceutical Continuous Manufacturing Market : https://www.zionmarketresearch.com/news/global-pharmaceutical-continuous-manufacturing-market
Browse Other Related Research Reports from Zion Market Research
- Respiratory Disorders Treatment Market - Global Industry Analysis: The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.
- Medical Enzyme Technology Market - Global Industry Analysis: The global Medical Enzyme Technology market accrued earnings worth approximately 4.5(USD Billion) in 2020 and is predicted to gain revenue of about 6.7(USD Billion) by 2028, is set to record a CAGR of nearly 6.2% over the period from 2021 to 2028.
- Oncolytic Virus Immunotherapy Market - Global Industry Analysis: The global Oncolytic Virus Immunotherapy market accrued earnings worth approximately301 (USD Million) in 2020 and is predicted to gain revenue of about 678(USD Million) by 2028, is set to record a CAGR of nearly 12.1% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
SOURCE Zion Market Research
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article